A first-in-class tri-complex KRAS(G13C)(ON) inhibitor validates therapeutic targeting of KRAS(G13C)and drives tumor regressions in preclinical modelsChristopher J. Schulze,Jim Cregg,Kyle J. Seamon,Yu Chi Yang,Zhican Wang,Lindsay S. Garrenton,Alun Bermingham,John E. Knox,Aidan Tomlinson,Kang-Jye Chou, Shaoling Li,David P. Wildes,Mallika Singh,Elena S. Koltun,Adrian L. Gill,Robert J. Nichols,Jacqueline A. SmithCANCER RESEARCH(2022)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要